Literature DB >> 9143304

The human cytomegalovirus UL97 protein is phosphorylated and a component of virions.

M van Zeijl1, J Fairhurst, E Z Baum, L Sun, T R Jones.   

Abstract

The expression of the human cytomegalovirus (HCMV) UL97 open reading frame in infected or transfected cells in the presence of the antiherpes compound ganciclovir (GCV) results in the intracellular phosphorylation of GCV. There are conventional kinase domains within the UL97-encoded protein (pUL97). However, the role of pUL97 in the HCMV replication cycle, and the mechanism by which it causes phosphorylation of GCV, are currently unknown. Herein, the biosynthesis and biogenesis of pUL97 was studied in HCMV-infected cells. pUL97 is expressed with early-late kinetics and is posttranslationally modified by phosphorylation. This phosphorylation occurs within 1 hr after synthesis, affects the electrophoretic mobility of pUL97, and is independent of the presence of other HCMV proteins. pUL97 was localized to the nucleus of infected cells and found in the HCMV virions. Thus, pUL97 is a virion phosphoprotein, and a likely tegument component.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143304     DOI: 10.1006/viro.1997.8523

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

1.  Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation.

Authors:  D G Wolf; C T Courcelle; M N Prichard; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 2.  Viral serine/threonine protein kinases.

Authors:  Thary Jacob; Céline Van den Broeke; Herman W Favoreel
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

3.  Human cytomegalovirus UL97 kinase alters the accumulation of CDK1.

Authors:  Rachel B Gill; Scott H James; Mark N Prichard
Journal:  J Gen Virol       Date:  2012-05-02       Impact factor: 3.891

4.  Nuclear trafficking of the human cytomegalovirus pp71 (ppUL82) tegument protein.

Authors:  Weiping Shen; Elizabeth Westgard; Liqun Huang; Michael D Ward; Jodi L Osborn; Nha H Chau; Lindsay Collins; Benjamin Marcum; Margaret A Koach; Jennifer Bibbs; O John Semmes; Julie A Kerry
Journal:  Virology       Date:  2008-04-18       Impact factor: 3.616

5.  Relationship between autophosphorylation and phosphorylation of exogenous substrates by the human cytomegalovirus UL97 protein kinase.

Authors:  Moon-Chang Baek; Paula M Krosky; Donald M Coen
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress.

Authors:  Natalia I Reim; Jeremy P Kamil; Depeng Wang; Alison Lin; Mayuri Sharma; Maria Ericsson; Jean M Pesola; David E Golan; Donald M Coen
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

7.  Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.

Authors:  Tarin M Bigley; Justin M Reitsma; Shama P Mirza; Scott S Terhune
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

8.  Cyclin-dependent kinase-like function is shared by the beta- and gamma- subset of the conserved herpesvirus protein kinases.

Authors:  Chad V Kuny; Karen Chinchilla; Michael R Culbertson; Robert F Kalejta
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

9.  An acidic cluster of human cytomegalovirus UL99 tegument protein is required for trafficking and function.

Authors:  Thomas R Jones; Shi-Wu Lee
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavir.

Authors:  Rachel B Gill; Samuel L Frederick; Caroll B Hartline; Sunwen Chou; Mark N Prichard
Journal:  Virol J       Date:  2009-01-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.